000 01034 a2200313 4500
005 20250516055733.0
264 0 _c20111104
008 201111s 0 0 fre d
022 _a1660-9379
040 _aNLM
_beng
_cNLM
100 1 _aChambaz, I Chatton
245 0 0 _a[Primary hyperaldosteronism].
_h[electronic resource]
260 _bRevue medicale suisse
_cSep 2011
300 _a1736-8, 1740-2 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdenoma
_xmetabolism
650 0 4 _aAdrenal Cortex Neoplasms
_xmetabolism
650 0 4 _aAdrenalectomy
650 0 4 _aAlgorithms
650 0 4 _aHumans
650 0 4 _aHyperaldosteronism
_xdiagnosis
650 0 4 _aHypertension
_xetiology
650 0 4 _aHypokalemia
_xetiology
650 0 4 _aMineralocorticoid Receptor Antagonists
_xtherapeutic use
650 0 4 _aSpironolactone
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aPechère-Bertschi, A
773 0 _tRevue medicale suisse
_gvol. 7
_gno. 308
_gp. 1736-8, 1740-2
999 _c21191846
_d21191846